MOLEKÜLE VON HDV-NUKLEINSÄUREN, IHRE FRAGMENTE UND ANWENDUNGEN

Isolated nucleic acids (I) for hepatitis D virus (HDV) are new. Isolated nucleic acids (I) for hepatitis D virus (HDV) comprising: (i) the genome of a HDV that, at the molecular level over the entire genome, has a divergence or genetic distance of at least 20% with respect to HDV of genotypes I-III;...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HUC-ANAIS, PATRICIA, DENY, PAUL, RADJEF, NADJIA
Format:	Patent
Sprache:	ger
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES OF PREPARING SUCH COMPOSITIONS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Isolated nucleic acids (I) for hepatitis D virus (HDV) are new. Isolated nucleic acids (I) for hepatitis D virus (HDV) comprising: (i) the genome of a HDV that, at the molecular level over the entire genome, has a divergence or genetic distance of at least 20% with respect to HDV of genotypes I-III; (ii) the genome of a HDV that, at the molecular level, has a divergence or genetic distance of at least 25% with respect to HDV of genotypes I-III over the 889-1289 region (R0); (iii) the complete genomes of the isolates or variants dFr-45, -47, -73, -910, -48, or -664; or (iv) a genome with a divergence or genetic distance less than 15% with respect to (iii). Independent claims are also included for: (1) specific fragments of (I); (2) detecting the specified HDV variants by hybridization and/or amplification; (3) detecting and genotyping HDV; (4) recombinant vectors, particularly plasmids, containing (I) or their fragments; (5) cells transformed with (I) or its fragments; (6) translation products (II) encoded by RNA of the specified variants; and (7) proteins encoded by (I), or its fragments, and their peptide fragments.